OR WAIT null SECS
Philip Ward is ACT's European editor, phone +44 1244 538583, email@example.com
The EMA has unveiled a new survey to assess how its communication strategy to the general public is perceived and valued by its stakeholders.
The European Medicines Agency (EMA) has unveiled a new survey to assess how its communication strategy to the general public is perceived and valued by its stakeholders.
The survey addresses how the agency communicates to the general public, and focuses on information made public mainly through the EMA website, including press releases and news announcements. EMA plans to distribute the results of the analysis.
“This will provide valuable feedback to help us to better plan and carry out our communication activities,” noted Monika Benstetter, Head of Media and Public Relations at EMA. “This is the second communications survey, the first having taken place in 2015, and it is anticipated that this exercise will be repeated every two years.”
The survey will be open until May 31, 2017, and Benstetter estimates that it should take you no longer than 10 minutes to complete. To access it, click here.